Development of adverse outcome pathways relevant for the identification of substances having endocrine disruption properties Uterine adenocarcinoma as adverse outcome

  1. Hernandez-Jerez, A.F.
  2. Adriaanse, P.
  3. Aldrich, A.
  4. Berny, P.
  5. Coja, T.
  6. Duquesne, S.
  7. Focks, A.
  8. Millet, M.
  9. Pelkonen, O.
  10. Pieper, S.
  11. Tiktak, A.
  12. Topping, C.J.
  13. Widenfalk, A.
  14. Wilks, M.
  15. Wolterink, G.
  16. Angeli, K.
  17. Recordati, C.
  18. Van Duursen, M.
  19. Aiassa, E.
  20. Lanzoni, A.
  21. Lostia, A.
  22. Martino, L.
  23. Guajardo, I.P.M.
  24. Panzarea, M.
  25. Terron, A.
  26. Marinovich, M.
  27. Show all authors +
Journal:
EFSA Journal

ISSN: 1831-4732

Year of publication: 2023

Volume: 21

Issue: 2

Type: Article

DOI: 10.2903/J.EFSA.2023.7744 GOOGLE SCHOLAR lock_openOpen access editor
Data source: Scopus